Daptomycin/rifampicin/vancomycinDevelopment of resistance in methicillin-resistant Staphylococcus aureus bacteremia: case report

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-017-33095-7
中图分类号
学科分类号
摘要
引用
收藏
页码:130 / 130
相关论文
共 50 条
  • [41] Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus
    Nannini, Esteban
    Murray, Barbara E.
    Arias, Cesar A.
    CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (05) : 516 - 521
  • [42] DAPTOMYCIN IS EFFECTIVE FOR INTRACTABLE VASCULAR GRAFT INFECTION BY METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS: A CASE REPORT
    Deguchi, H.
    Mori, Y.
    Tokunaga, Koki
    Takenouchi, S.
    Mishige, Y.
    Nakashima, A.
    NEPHROLOGY, 2014, 19 : 89 - 89
  • [43] Case Report of a Successful Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia and MRSA/Vancomycin-Resistant Enterococcus faecium Cholecystitis by Daptomycin
    Tascini, Carlo
    Di Paolo, Antonello
    Polillo, Marialuisa
    Ferrari, Mauro
    Lambelet, Paola
    Danesi, Romano
    Menichetti, Francesco
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (05) : 2458 - 2459
  • [44] Methicillin-resistant Staphylococcus aureus (MRSA) - case report
    Linde, H
    Lehn, N
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (11) : 581 - 581
  • [45] Considerations for Higher Doses of Daptomycin in Critically Ill Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia
    Falcone, Marco
    Russo, Alessandro
    Venditti, Mario
    Novelli, Andrea
    Pai, Manjunath P.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (11) : 1568 - 1576
  • [46] Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus Bacteremia
    Hirschwerk, David
    Ginocchio, Christine C.
    Bythrow, Maureen
    Condon, Susan
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006, 27 (03): : 315 - 317
  • [47] Implementation of an Antimicrobial Stewardship Pathway with Daptomycin for Optimal Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
    Kullar, Ravina
    Davis, Susan L.
    Kaye, Keith S.
    Levine, Donald P.
    Pogue, Jason M.
    Rybak, Michael J.
    PHARMACOTHERAPY, 2013, 33 (01): : 3 - 10
  • [48] Ceftaroline for the treatment of methicillin-resistant Staphylococcus aureus bacteremia
    White, Bryin Pinckney
    Barber, Katie E.
    Stover, Kayla R.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (04) : 201 - 208
  • [49] Optimizing therapy for methicillin-resistant Staphylococcus aureus bacteremia
    Cosgrove, Sara E.
    Fowler, Vance G., Jr.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 28 (06) : 624 - 631
  • [50] Evaluation of the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
    Usery, Justin B.
    Vo, Ngan H.
    Finch, Christopher K.
    Cleveland, Kerry O.
    Gelfand, Michael S.
    Self, Timothy H.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 349 (01): : 36 - 41